285 related articles for article (PubMed ID: 20061426)
1. Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.
Miller KK; Wexler T; Fazeli P; Gunnell L; Graham GJ; Beauregard C; Hemphill L; Nachtigall L; Loeffler J; Swearingen B; Biller BM; Klibanski A
J Clin Endocrinol Metab; 2010 Feb; 95(2):567-77. PubMed ID: 20061426
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.
Beauregard C; Utz AL; Schaub AE; Nachtigall L; Biller BM; Miller KK; Klibanski A
J Clin Endocrinol Metab; 2008 Jun; 93(6):2063-71. PubMed ID: 18381581
[TBL] [Abstract][Full Text] [Related]
3. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly.
Lin E; Wexler TL; Nachtigall L; Tritos N; Swearingen B; Hemphill L; Loeffler J; Biller BM; Klibanski A; Miller KK
Clin Endocrinol (Oxf); 2012 Sep; 77(3):430-8. PubMed ID: 22315983
[TBL] [Abstract][Full Text] [Related]
4. Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders.
Valassi E; Brick DJ; Johnson JC; Biller BM; Klibanski A; Miller KK
Endocr Pract; 2012; 18(2):209-18. PubMed ID: 22440981
[TBL] [Abstract][Full Text] [Related]
5. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.
Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173
[TBL] [Abstract][Full Text] [Related]
6. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
[TBL] [Abstract][Full Text] [Related]
7. Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.
Norrman LL; Johannsson G; Sunnerhagen KS; Svensson J
J Clin Endocrinol Metab; 2008 Jul; 93(7):2531-8. PubMed ID: 18397981
[TBL] [Abstract][Full Text] [Related]
8. Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity.
Bredella MA; Gerweck AV; Lin E; Landa MG; Torriani M; Schoenfeld DA; Hemphill LC; Miller KK
J Clin Endocrinol Metab; 2013 Sep; 98(9):3864-72. PubMed ID: 23824419
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.
Sesmilo G; Fairfield WP; Katznelson L; Pulaski K; Freda PU; Bonert V; Dimaraki E; Stavrou S; Vance ML; Hayden D; Klibanski A
J Clin Endocrinol Metab; 2002 Apr; 87(4):1692-9. PubMed ID: 11932303
[TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly.
Fazeli PK; Teoh JG; Lam EL; Gerweck AV; Wexler TL; Teo EP; Russell BM; Durst R; McCarty D; Weiner RB; Picard MH; Klibanski A; Miller KK
Growth Horm IGF Res; 2016 Feb; 26():17-23. PubMed ID: 26774401
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly.
Wexler T; Gunnell L; Omer Z; Kuhlthau K; Beauregard C; Graham G; Utz AL; Biller B; Nachtigall L; Loeffler J; Swearingen B; Klibanski A; Miller KK
J Clin Endocrinol Metab; 2009 Jul; 94(7):2471-7. PubMed ID: 19366847
[TBL] [Abstract][Full Text] [Related]
12. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.
Vahl N; Juul A; Jørgensen JO; Orskov H; Skakkebaek NE; Christiansen JS
J Clin Endocrinol Metab; 2000 May; 85(5):1874-81. PubMed ID: 10843168
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Bunderen CC; van Varsseveld NC; Heymans MW; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Eur J Endocrinol; 2014 Dec; 171(6):717-26. PubMed ID: 25227133
[TBL] [Abstract][Full Text] [Related]
14. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.
Lo J; You SM; Canavan B; Liebau J; Beltrani G; Koutkia P; Hemphill L; Lee H; Grinspoon S
JAMA; 2008 Aug; 300(5):509-19. PubMed ID: 18677023
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.
Rodríguez-Arnao J; Jabbar A; Fulcher K; Besser GM; Ross RJ
Clin Endocrinol (Oxf); 1999 Jul; 51(1):53-60. PubMed ID: 10468965
[TBL] [Abstract][Full Text] [Related]
16. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
17. Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.
Bredella MA; Lin E; Brick DJ; Gerweck AV; Harrington LM; Torriani M; Thomas BJ; Schoenfeld DA; Breggia A; Rosen CJ; Hemphill LC; Wu Z; Rifai N; Utz AL; Miller KK
Eur J Endocrinol; 2012 Apr; 166(4):601-11. PubMed ID: 22275471
[TBL] [Abstract][Full Text] [Related]
18. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.
Janssen JA; van der Toorn FM; Hofland LJ; van Koetsveld P; Broglio F; Ghigo E; Lamberts SW; Jan van der Lely A
Eur J Endocrinol; 2001 Dec; 145(6):711-6. PubMed ID: 11720895
[TBL] [Abstract][Full Text] [Related]
19. Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment.
Arlien-Søborg MC; Madsen MA; Dal J; Krusenstjerna-Hafstrøm T; Ringgaard S; Skou N; Høgild M; Jørgensen JOL
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651164
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
